318 related articles for article (PubMed ID: 38062689)
41. Possible COVID-19-Associated Pulmonary Aspergillosis Due to
Katsiari M; Mavroidi A; Palla E; Zourla K; Alonistiotis T; Ntorlis K; Nikolaou C; Vrioni G; Tsakris A
Antibiotics (Basel); 2022 Feb; 11(3):. PubMed ID: 35326764
[TBL] [Abstract][Full Text] [Related]
42. Mucormycosis: New Developments into a Persistently Devastating Infection.
Danion F; Aguilar C; Catherinot E; Alanio A; DeWolf S; Lortholary O; Lanternier F
Semin Respir Crit Care Med; 2015 Oct; 36(5):692-705. PubMed ID: 26398536
[TBL] [Abstract][Full Text] [Related]
43. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.
Verweij PE; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Buil JB; Calandra T; Chiller T; Clancy CJ; Cornely OA; Depuydt P; Koehler P; Lagrou K; de Lange D; Lass-Flörl C; Lewis RE; Lortholary O; Liu PL; Maertens J; Nguyen MH; Patterson TF; Rijnders BJA; Rodriguez A; Rogers TR; Schouten JA; Wauters J; van de Veerdonk FL; Martin-Loeches I
Intensive Care Med; 2021 Aug; 47(8):819-834. PubMed ID: 34160631
[TBL] [Abstract][Full Text] [Related]
44. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.
Chong WH; Neu KP
J Hosp Infect; 2021 Jul; 113():115-129. PubMed ID: 33891985
[TBL] [Abstract][Full Text] [Related]
45. Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
Clemons KV; Espiritu M; Parmar R; Stevens DA
Antimicrob Agents Chemother; 2005 Dec; 49(12):4867-75. PubMed ID: 16304147
[TBL] [Abstract][Full Text] [Related]
46. Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients.
Maschmeyer G; Haas A; Cornely OA
Drugs; 2007; 67(11):1567-601. PubMed ID: 17661528
[TBL] [Abstract][Full Text] [Related]
47. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.
Gangneux JP; Dannaoui E; Fekkar A; Luyt CE; Botterel F; De Prost N; Tadié JM; Reizine F; Houzé S; Timsit JF; Iriart X; Riu-Poulenc B; Sendid B; Nseir S; Persat F; Wallet F; Le Pape P; Canet E; Novara A; Manai M; Cateau E; Thille AW; Brun S; Cohen Y; Alanio A; Mégarbane B; Cornet M; Terzi N; Lamhaut L; Sabourin E; Desoubeaux G; Ehrmann S; Hennequin C; Voiriot G; Nevez G; Aubron C; Letscher-Bru V; Meziani F; Blaize M; Mayaux J; Monsel A; Boquel F; Robert-Gangneux F; Le Tulzo Y; Seguin P; Guegan H; Autier B; Lesouhaitier M; Pelletier R; Belaz S; Bonnal C; Berry A; Leroy J; François N; Richard JC; Paulus S; Argaud L; Dupont D; Menotti J; Morio F; Soulié M; Schwebel C; Garnaud C; Guitard J; Le Gal S; Quinio D; Morcet J; Laviolle B; Zahar JR; Bougnoux ME
Lancet Respir Med; 2022 Feb; 10(2):180-190. PubMed ID: 34843666
[TBL] [Abstract][Full Text] [Related]
48. COVID-19-associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID-19 patients.
Calderón-Parra J; Mills-Sanchez P; Moreno-Torres V; Tejado-Bravo S; Romero-Sánchez I; Balandin-Moreno B; Calvo-Salvador M; Portero-Azorín F; García-Masedo S; Muñez-Rubio E; Ramos-Martinez A; Fernández-Cruz A;
Mycoses; 2022 May; 65(5):541-550. PubMed ID: 35212030
[TBL] [Abstract][Full Text] [Related]
49. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
50. Antifungal Liposomes Directed by Dectin-2 Offer a Promising Therapeutic Option for Pulmonary Aspergillosis.
Ambati S; Ellis EC; Pham T; Lewis ZA; Lin X; Meagher RB
mBio; 2021 Feb; 12(1):. PubMed ID: 33622715
[TBL] [Abstract][Full Text] [Related]
51. High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation.
Feys S; Lagrou K; Lauwers HM; Haenen K; Jacobs C; Brusselmans M; Debaveye Y; Hermans G; Hoenigl M; Maertens J; Meersseman P; Peetermans M; Spriet I; Vandenbriele C; Vanderbeke L; Vos R; Van Wijngaerden E; Wilmer A; Wauters J
Clin Infect Dis; 2024 Feb; 78(2):361-370. PubMed ID: 37691392
[TBL] [Abstract][Full Text] [Related]
52. Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.
Kim SH; Hong JY; Bae S; Lee H; Wi YM; Ko JH; Kim B; Joo EJ; Seok H; Shi HJ; Yoo JR; Hyun M; Kim HA; Jang S; Mun SJ; Kim J; Kim MC; Jung DS; Kim SH; Peck KR
J Korean Med Sci; 2022 May; 37(18):e134. PubMed ID: 35535369
[TBL] [Abstract][Full Text] [Related]
53. Invasive Pulmonary Aspergillosis in Coronavirus Disease 2019 Patients Lights and Shadows in the Current Landscape.
Tsotsolis S; Kotoulas SC; Lavrentieva A
Adv Respir Med; 2023 May; 91(3):185-202. PubMed ID: 37218799
[TBL] [Abstract][Full Text] [Related]
54. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.
Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M;
Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093
[TBL] [Abstract][Full Text] [Related]
55. [Pulmonary mucormycosis: report of 5 cases and review of 46 cases reported in China].
Yang YM; Fang BM; Xu XM; Fang F; Pan MM; Zhong XF; Sun TY
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):572-6. PubMed ID: 24252732
[TBL] [Abstract][Full Text] [Related]
56. Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia.
Rickerts V; Atta J; Herrmann S; Jacobi V; Lambrecht E; Bialek R; Just-Nübling G
Mycoses; 2006; 49 Suppl 1():27-30. PubMed ID: 16961579
[TBL] [Abstract][Full Text] [Related]
57. COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study.
Tamayo-Velasco Á; López-Herrero R; Gómez-García LM; Sánchez-de Prada L; Aguilar-Monserrate G; Martín-Fernández M; Bardají-Carrillo M; Álvaro-Meca A; Tamayo E; Resino S; Miramontes-González JP; Peñarrubia-Ponce MJ
J Infect Public Health; 2024 Jun; 17(6):939-946. PubMed ID: 38613930
[TBL] [Abstract][Full Text] [Related]
58. COVID-19-associated pulmonary aspergillosis: an underdiagnosed or overtreated infection?
Rouzé A; Martin-Loeches I; Nseir S
Curr Opin Crit Care; 2022 Oct; 28(5):470-479. PubMed ID: 35950729
[TBL] [Abstract][Full Text] [Related]
59. An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
Sehgal IS; Dhooria S; Muthu V; Prasad KT; Agarwal R
Expert Rev Respir Med; 2020 Jul; 14(7):715-727. PubMed ID: 32249630
[TBL] [Abstract][Full Text] [Related]
60. Nebulized Amphotericin B in Mechanically Ventilated COVID-19 Patients to Prevent Invasive Pulmonary Aspergillosis: A Retrospective Cohort Study.
Melchers M; van Zanten ARH; Heusinkveld M; Leeuwis JW; Schellaars R; Lammers HJW; Kreemer FJ; Haas PJ; Verweij PE; van Bree SHW
Crit Care Explor; 2022 May; 4(5):e0696. PubMed ID: 35558738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]